Interviews, Articles & Podcasts
Labiotech
CEO Brian Culley discusses the OPC1 program and the challenges associated with clinical trials in the SCI space
October 7, 2024
BioTechTV
CEO Brian Culley describes the idea behind organizing the Spinal Cord Injury Investor Symposium and gives an overview of Lineage’s cell therapy approach
June 26, 2024
Business of BioTech
CEO Brian Culley met with @mattpillar on the Business of Biotech Podcast to share insights into our spinal cord injury program and our journey of innovation and resilience.
June 24, 2024
Finding the recipe for success in cell therapy
Longevity.Technology News interviews Lineage CEO Brian Culley to learn why cell therapy may play a key role in improving human longevity.
August 03, 2023
CEO Brian Culley discusses how Lineage is treating disease by replacing lost cells with functional cells via transplant therapy.
Talking Biotech Podcast
July 15, 2023
Credibility, Cash, and Capability: The Benefits of Strategic Partnership, with Brian Culley, Lineage Cell Therapeutics
Ophthalmology Innovation Source (OIS) Podcast
June 16, 2023
Manufacturing Auditory Neurons with Brian Culley, CEO of Lineage Cell Therapeutics.
This Week in Hearing
May 22, 2023
Presentations from specific events, conferences, or showcases
Key opinion leaders discuss topics related to Lineage’s clinical programs
Richard Fessler, MD, Professor of Neurosurgery, Rush University Medical School, discusses data seen in the phase 1/2 clinical trial of OPC1 for spinal cord injury (watch on CGTLive.com)
July 20, 2022
Review of the pathogenesis of AMD and the pathways to CNV and GA
Jordi Monés, M.D., Ph.D., Director, Institut de la Màcula and Director, Principal Investigator and Founder, Barcelona Macula Foundation
OpRegen® Phase 1/2a Clinical Study Results
2020 ARVO Meeting
Christopher D. Riemann, M.D., Cincinnati Eye Institute (CEI)
Why is dry age-related macular degeneration (dry AMD) research so important?
Allen C. Ho, M.D., Wills Eye Hospital Director of Retina Research
Why is spinal cord research so important?
Dr. John Steeves, Emeritus Principal Investigator @ICORD and Professor @UBC
A selection of patient focused media related to our cell therapy programs
The Stem Cellar
The Official Blog of CIRM, California’s Stem Cell Agency
Where Are They Now: Jake Javier
Pioneering Cell Transplants for the Treatment of Spinal Cord Injury
Christopher and Dana Reeve Foundation Blog
OPC1 Patient Spotlight – Chris Block – Part 1
In 2016, Chris Block was paralyzed in a bicycling accident. In 2023, he is an avid scuba diver, horseback rider and, importantly, has his independence.
OPC1 Patient Spotlight – Chris Block – Part 2
In 2016, Chris Block was paralyzed in a bicycling accident. In 2023, he is an avid scuba diver, horseback rider and, importantly, has his independence.
The Stem Cellar
The Official Blog of CIRM, California’s Stem Cell Agency
Update on spinal cord injury patient Jake Javier, enrolled in CIRM-funded stem cell clinical trial
OPC1 Program – Patient Spotlight – Jake Javier
In 2016, Jake Javier was paralyzed from the neck down. In late 2022, he is set to graduate from Duke University with his Master’s Degree in Biomedical Engineering, with plans to help those impacted by neurological injuries or diseases.
Sonia Cohen’s OpRegen Story
OpRegen for Dry AMD | Lineage Cell Therapeutics
Cheri’s Story
OpRegen for Dry AMD | Lineage Cell Therapeutics
WDAM7 Mississippi
“New Treatment for Age-Related Dry Macular Degeneration”
5 years through the eyes of a mum.
A powerful dramatization of living with the progression of vision loss related to AMD. Source: www.macularsociety.org
Spinal Cord Injury and Lineage’s OPC1 Cell Therapy
An instructive whiteboard video explaining how spinal cord injury disrupts normal bodily function as well as OPC1 administration and mechanism of action.
OPC1 Program – Patient Spotlight – Kris Boesen and Lucas Lindner
Highlighting the progress made by Kris Boesen and Lucas Lindner, both of whom received Lineage’s OPC1 cell therapy following traumatic spinal cord injury (SCI).
Lucas Lindner was paralyzed from the neck down following a car accident. The next year, he threw out the first pitch at a Major League Baseball game.
Watch the video above to learn more about Lucas’ journey.